Literature DB >> 32844080

Valuing Protection against Health-Related Financial Risks.

Jonathan Skinner1, Kalipso Chalkidou2, Dean T Jamison3.   

Abstract

There is strong interest in both developing and developed countries towards expanding health insurance coverage. How should the benefits, and costs, of expanded coverage be measured? While the value of reducing the financial risks that result from insurance coverage have long been recognized, there has been less attention in how best to measure such benefits. In this paper, we first provide a framework for assessing the financial value from health insurance. We focus on 3 distinct potential benefits: Pooling the risk of unexpected medical expenditures between healthy and sick households, redistributing resources from high to low income recipients, and smoothing consumption over time. We then use this theoretical framework and an illustrative example to provide practical guidelines for benefit-cost analysis in capturing the full benefits (and costs) of expanding health insurance coverage. We conclude by considering other potential financial effects of broad insurance coverage, such as the ability to consolidate purchases and thus lower input prices.

Entities:  

Year:  2019        PMID: 32844080      PMCID: PMC7444749          DOI: 10.1017/bca.2018.30

Source DB:  PubMed          Journal:  J Benefit Cost Anal        ISSN: 2152-2812


  30 in total

1.  Catastrophe and impoverishment in paying for health care: with applications to Vietnam 1993-1998.

Authors:  Adam Wagstaff; Eddy van Doorslaer
Journal:  Health Econ       Date:  2003-11       Impact factor: 3.046

2.  Incorporating financial protection into decision rules for publicly financed healthcare treatments.

Authors:  Peter C Smith
Journal:  Health Econ       Date:  2012-01-13       Impact factor: 3.046

3.  A new estimate of the welfare loss of excess health insurance.

Authors:  R Feldman; B Dowd
Journal:  Am Econ Rev       Date:  1991-03

4.  Effect of payments for health care on poverty estimates in 11 countries in Asia: an analysis of household survey data.

Authors:  Eddy van Doorslaer; Owen O'Donnell; Ravi P Rannan-Eliya; Aparnaa Somanathan; Shiva Raj Adhikari; Charu C Garg; Deni Harbianto; Alejandro N Herrin; Mohammed Nazmul Huq; Shamsia Ibragimova; Anup Karan; Chiu Wan Ng; Badri Raj Pande; Rachel Racelis; Sihai Tao; Keith Tin; Kanjana Tisayaticom; Laksono Trisnantoro; Chitpranee Vasavid; Yuxin Zhao
Journal:  Lancet       Date:  2006-10-14       Impact factor: 79.321

5.  Progressive universalism? The impact of targeted coverage on health care access and expenditures in Peru.

Authors:  Sven Neelsen; Owen O'Donnell
Journal:  Health Econ       Date:  2017-02-16       Impact factor: 3.046

6.  Universal public finance of tuberculosis treatment in India: an extended cost-effectiveness analysis.

Authors:  Stéphane Verguet; Ramanan Laxminarayan; Dean T Jamison
Journal:  Health Econ       Date:  2014-02-04       Impact factor: 3.046

7.  The insurance value of Medicare.

Authors:  Katherine Baicker; Helen Levy
Journal:  N Engl J Med       Date:  2012-10-31       Impact factor: 91.245

Review 8.  Health systems development in Thailand: a solid platform for successful implementation of universal health coverage.

Authors:  Viroj Tangcharoensathien; Woranan Witthayapipopsakul; Warisa Panichkriangkrai; Walaiporn Patcharanarumol; Anne Mills
Journal:  Lancet       Date:  2018-02-01       Impact factor: 79.321

9.  All roads lead to universal health coverage.

Authors:  Tedros Adhanom Ghebreyesus
Journal:  Lancet Glob Health       Date:  2017-07-17       Impact factor: 26.763

10.  Distributional cost-effectiveness analysis of health care programmes--a methodological case study of the UK Bowel Cancer Screening Programme.

Authors:  Miqdad Asaria; Susan Griffin; Richard Cookson; Sophie Whyte; Paul Tappenden
Journal:  Health Econ       Date:  2014-05-02       Impact factor: 3.046

View more
  1 in total

1.  Conducting Benefit-Cost Analysis in Low- and Middle-Income Countries: Introduction to the Special Issue.

Authors:  Lisa A Robinson; James K Hammitt; Dean T Jamison; Damian G Walker
Journal:  J Benefit Cost Anal       Date:  2019-02-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.